Product Search |
|
| Input Product Name Or Cas No. |
Category |
Products |
adamantane-1-carbothioic O-acid |
Methyl 4-(methacryloyloxy)benzoate |
1,1,2,2,3,3,4,4-Octafluorobutyl 2-methyl |
4-Iodo-3-thiophenecarboxylic acid |
3H-1,2-Benziodazol-3-one, 2-acetyl-1-(ac |
Ethanone, 1-(2,2-dioxidonaphtho[1,8-cd]- |
3H-1,2-Benziodazol-3-one, 1-acetoxy-1,2- |
2-Methylpropyl 4-chlorobenzenesulfonate |
[4-(Dimethylamino)phenyl]diphenylsulfoni |
4-(3-Ethoxy-3-oxo-1-propyn-1-yl)benzoic |
Ethanone, 1-[4,6-bis(trichloromethyl)-1, |
Benzenemethanol, 2-hydroxy-3-[[2-hydroxy |
Hexahydro-4,7-epoxyisobenzofuran-1(3H)-o |
2-(1,1-Dimethylethyl)-5-fluoropyrazine |
5-(1,1-Dimethylethyl)-2-fluoropyrimidine |
2-Fluoro-5-(2-furanyl)pyrazine |
2-Fluoro-5-(2-furanyl)pyrimidine |
2-Fluoro-5-(2-thiazolyl)pyrazine |
2-Fluoro-5-(2-thiazolyl)pyrimidine |
2,5-Difluoropyrazine |
2-Fluoro-5-(trifluoromethyl)pyrimidine |
2-Fluoro-5-methylpyrazine |
2-Ethenylbenzeneacetonitrile |
4-((methylsulfonyl)oxy)benzenesulfonic a |
4-(((4-((methylsulfonyl)oxy)phenyl)sulfo |
2-phenyl-2-(5-(((phenylsulfonyl)oxy)imin |
4-((((5-(cyano(o-tolyl)methylene)thiophe |
4-((((5-(cyano(o-tolyl)methylene)thiophe |
4-((((5-(cyano(m-tolyl)methylene)thiophe |
4-((((5-(cyano(2-vinylphenyl)methylene)t |
2-(5-(hydroxyimino)thiophen-2(5H)-yliden |
4-((((5-([1,1’-biphenyl]-2-yl(cyano)me |
4-((((5-(cyano(o-tolyl)methylene)thiophe |
2-([1,1’-biphenyl]-2-yl)-2-(5-(hydroxy |
Tetrahydro-4H-thiopyran-4,4-dimethanol |
triphenylsulfonium 2-(3-(2,2-difluoro-2- |
triphenylsulfonium 2-(3-(2,2-difluoro-2- |
triphenylsulfonium 2-((1-((2,2-difluoro- |
3-hydroxy-2,2-dimethylpropyl 2,2-difluor |
3-hydroxy-2,2-dimethylpropyl 4-oxoadaman |
(1-(hydroxymethyl)cyclopropyl)methyl 4-o |
1-Ethylbicyclo[2.2.1]hept-2-ene |
1-Phenylbicyclo[2.2.1]hept-2-ene |
3-Dimethylamino-6-methyl-7-anilinofluora |
5-Methoxybicyclo[2.2.1]hept-2-ene |
6′-(Dipropylamino)-3′-methyl-2′-(p |
2-propyladamantan-2-ol |
Dihydro-4-hydroxy-3-methyl-2(3H)-furanon |
3-Ethyldihydro-4-hydroxy-2(3H)-furanone |
3-fluoro-4-(methacryloyloxy)benzenesulfo |
|
Products |
| Catalogue Number |
Products |
CAS No. |
Assay |
| RovathinS26811 | Benzo[b]thiophene-2-sulfonamide, 5-chloro-N-[4-methoxy-3-(1-piperazinyl)phenyl]-3-methyl- | 209481-20-9 | 95% |
| RovathinS26812 | Pyrrolidine, 1-[(6-fluoro-2,9-dihydro-9-methyl-1-oxo-2-phenyl-1H-pyrido[3,4-b]indol-4-yl)carbonyl]- | 205881-86-3 | 95% |
| RovathinS26813 | [1,1'-Biphenyl]-4-carboxamide, N-[3-[2-(dimethylamino)ethoxy]-4-methoxyphenyl]-2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)-, monohydrochloride | 193611-67-5 | 95% |
| RovathinS26814 | 7H-Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine, 2-(2-furanyl)-7-(2-phenylethyl)- | 160098-96-4 | 95% |
| RovathinS26815 | 1H-Imidazole, 1-[2-(4-methoxyphenyl)-2-[3-(4-methoxyphenyl)propoxy]ethyl]-, monohydrochloride | 130495-35-1 | 95% |
| RovathinS26816 | 2-Imidazolidinone, 1-[2-[4-[5-chloro-1-(4-fluorophenyl)-1H-indol-3-yl]-1-piperidinyl]ethyl]- | 106516-24-9 | 95% |
| RovathinS26817 | 1H-3-Benzazepin-7-ol, 8-bromo-2,3,4,5-tetrahydro-3-methyl-5-phenyl- | 99295-33-7 | 95% |
| RovathinS26818 | 1-Naphthalenesulfonamide, 5-(dimethylamino)-N-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]- | 390803-39-1 | 95% |
| RovathinS26819 | 4H-Pyrido[1,2-a]pyrimidin-4-one, 2-[[6-methoxy-4-(1-methylethyl)-1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl]methoxy]-9-[2-(1-piperidinyl)ethoxy]- | 344930-95-6 | 95% |
| RovathinS26820 | 1H-Indole-5-sulfonamide, 2,3-dihydro-N,N-dimethyl-2-oxo-3-[(4,5,6,7-tetrahydro-1H-indol-2-yl)methylene]- | 330161-87-0 | 95% |
| RovathinS26821 | Thieno[2,3-b]pyridine-5-carboxylic acid, 7-[(2,6-difluorophenyl)methyl]-4,7-dihydro-2-[4-[(2-methyl-1-oxopropyl)amino]phenyl]-3-[[methyl(phenylmethyl)amino]methyl]-4-oxo-, 1-methylethyl ester | 199119-18-1 | 95% |
| RovathinS26822 | Thieno[2,3-b]pyridine-5-carboxylic acid, 7-[(2,6-difluorophenyl)methyl]-4,7-dihydro-2-[4-[(2-methyl-1-oxopropyl)amino]phenyl]-3-[[methyl(phenylmethyl)amino]methyl]-4-oxo-, 1-methylethyl ester, monohyd | 192887-28-8 | 95% |
| RovathinS26823 | Tricyclo[3.3.1.13,7]decane-2-carboxylic acid, 2-[[[1-(7-chloro-4-quinolinyl)-5-(2,6-dimethoxyphenyl)-1H-pyrazol-3-yl]carbonyl]amino]- | 146362-70-1 | 95% |
| RovathinS26824 | 1H-Indole-1-acetic acid, 2-[[[4-(2-chlorophenyl)-2-thiazolyl]amino]carbonyl]- | 136381-85-6 | 95% |
| RovathinS26825 | 3-[2-(Dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide | 103628-46-2 | 95% |
| RovathinS26826 | 2-Imidazoline, 2-(2,6-diethylanilino)-, hydrochloride | 4749-61-5 | 95% |
| RovathinS26827 | 7-Methyl-2-(morpholin-4-yl)-9-[1-(phenylamino)ethyl]pyrido[1,2-a]pyrimidin-4-one | 663619-89-4 | 95% |
| RovathinS26828 | 2(1H)-Quinolinethione, 7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro- | 573691-04-0 | 95% |
| RovathinS26829 | 4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline | 443913-73-3 | 95% |
| RovathinS26830 | 1H-Inden-2-amine, 2,3-dihydro-5,6-dimethoxy-N,N-dipropyl- | 82668-33-5 | 95% |
| RovathinS26831 | 6,7-Dihydroxy-2-dimethylaminotetralin | 66543-77-9 | 95% |
| RovathinS26832 | 2-(Di-n-propylamino)-6,7-dihydroxytetralin | 66185-60-2 | 95% |
| RovathinS26833 | 2-(Di-n-propylamino)-5,6-dihydroxytetralin | 64309-39-3 | 95% |
| RovathinS26834 | 2,3-Naphthalenediol, 6-(dimethylamino)-5,6,7,8-tetrahydro-, hydrobromide | 62421-56-1 | 95% |
| RovathinS26835 | Thiazolo[3,2-a]benzimidazole-2-carboxamide, 6-amino-N-cyclohexyl-N,3-dimethyl- | 748758-45-4 | 95% |
| RovathinS26836 | Cyclohexanecarboxamide, N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinyl- | 162760-96-5 | 95% |
| RovathinS26837 | 2,3-Quinoxalinedione, 1,4-dihydro-6-(1H-imidazol-1-yl)-7-nitro-, monohydrochloride | 154164-30-4 | 95% |
| RovathinS26838 | Cyclohexanecarboxamide, N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinyl-, trihydrochloride | 146714-97-8 | 95% |
| RovathinS26839 | 3(2H)-Pyridazinone, 6-[4-(difluoromethoxy)-3-methoxyphenyl]- | 101975-10-4 | 95% |
| RovathinS26840 | 2H-3-Benzazepin-2-one, 3-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-, monohydrochloride | 91940-87-3 | 95% |
|
|
|
|